Immediate Discontinuation of Sliding-Scale Insulin and Transition to Scheduled Basal-Bolus Therapy

This 70-year-old nursing home resident with glucose ranging 70–500 mg/dL on a reactive sliding-scale regimen requires immediate conversion to a scheduled basal-bolus insulin approach, because sliding-scale insulin as monotherapy is explicitly condemned by all major diabetes guidelines and achieves target glucose in only ~38% of patients versus ~68% with basal-bolus therapy. 12

Critical Problems with the Current Regimen

Sliding-scale insulin treats hyperglycemia only after it occurs, producing dangerous glucose fluctuations that worsen both hyper- and hypoglycemia rather than preventing them. 12
The current approach—Lantus 12 U "if glucose >200 mg/dL" and Humalog 6 U twice daily "if glucose >200 mg/dL"—is not a true basal-bolus regimen but rather a reactive correction-only strategy that provides no scheduled basal coverage and no scheduled prandial insulin. 13
No basal insulin is suppressing hepatic glucose production overnight or between meals, leading to persistent fasting hyperglycemia (glucose up to 500 mg/dL). 12
Absence of scheduled prandial insulin causes post-prandial spikes that are later corrected with large reactive doses, creating a cycle of hyperglycemia → large correction → hypoglycemia (glucose 70 mg/dL) → rebound hyperglycemia. 12
In nursing home residents, nearly two-thirds of those with hypoglycemia also have hyperglycemia, and efforts to de-intensify must address both simultaneously by tailoring insulin timing and type. 4
Hypoglycemia occurs in 26% of nursing home residents on sliding-scale insulin within 30 days, and the average fingerstick burden is ~4 checks per day. 5

Recommended Basal-Bolus Insulin Regimen

Step 1: Calculate Total Daily Insulin Dose (TDD)

Review the average total insulin used over the past 5–7 days from the sliding-scale records (Lantus + Humalog doses). 1
For a nursing home resident with wide glucose fluctuations (70–500 mg/dL), a reasonable starting TDD is 0.3–0.5 U/kg/day for severe hyperglycemia. 3
If the patient weighs ~70 kg, this translates to 21–35 U/day total. 3

Step 2: Allocate Basal Insulin (50% of TDD)

Give 50% of the TDD as scheduled basal insulin once daily (e.g., 11–18 U of insulin glargine). 13
Administer Lantus at the same time every day (bedtime is traditional, but morning dosing may reduce early-morning hypoglycemia risk in elderly patients). 67
Do NOT give basal insulin "if glucose >200 mg/dL"—it must be scheduled regardless of glucose level to suppress hepatic glucose output. 188

Step 3: Allocate Prandial Insulin (50% of TDD)

Give the remaining 50% of TDD as scheduled rapid-acting insulin divided among three meals (e.g., 4–6 U Humalog before breakfast, lunch, and dinner). 13
Administer Humalog 0–15 minutes before meals, not "if glucose >200 mg/dL." 3
For nursing home residents with irregular dietary intake or cognitive decline, the AMDA guidelines suggest a simplified approach: "give 4 units of mealtime insulin if glucose >300 mg/dL" as a safety measure, but scheduled doses are still preferred. 1

Step 4: Add Correction Doses (Adjunct Only)

Correction insulin must supplement—not replace—scheduled basal and prandial doses. 13
Use a simplified correction scale: 2 U Humalog for pre-meal glucose >250 mg/dL and 4 U for glucose >350 mg/dL, given in addition to the scheduled prandial dose. 3

Titration Protocol

Basal Insulin (Lantus) Titration

Increase Lantus by 2 U every 3 days if fasting glucose is 140–179 mg/dL. 7
Increase Lantus by 4 U every 3 days if fasting glucose ≥180 mg/dL. 7
Target fasting glucose: 80–130 mg/dL (or 90–150 mg/dL for elderly patients with complex health). 67
If any glucose reading falls <70 mg/dL, reduce the current basal dose by 10–20% immediately. 37
Stop basal escalation when the dose approaches 0.5 U/kg/day (~35 U for a 70-kg patient) without achieving targets; at this point, focus on intensifying prandial insulin to avoid "over-basalization." 37

Prandial Insulin (Humalog) Titration

Increase each meal dose by 1–2 U every 3 days based on 2-hour post-prandial glucose readings. 3
Target post-prandial glucose: <180 mg/dL. 3
If hypoglycemia occurs after a meal, reduce that specific meal dose by 10–20%. 3

Monitoring Requirements

Daily fasting glucose to guide basal insulin adjustments. 7
Pre-meal glucose before each meal to calculate correction doses. 3
2-hour post-prandial glucose after meals to assess prandial adequacy. 3
Bedtime glucose to evaluate overall daily pattern. 3
For nursing home residents with poor oral intake or irregular eating, check glucose every 4–6 hours and use a basal-plus-correction regimen (basal insulin + correction doses only, no scheduled prandial). 3

Special Considerations for Nursing Home Residents

Wide glucose fluctuations (70–500 mg/dL) indicate both inadequate basal coverage AND postprandial excursions, requiring both basal and prandial insulin. 14
For residents with cognitive decline or irregular dietary intake, the AMDA guidelines recommend: "Use scheduled basal and mealtime insulin based on individual needs with the goal of avoiding hypoglycemia. May use a simple scale, such as 'give 4 units of mealtime insulin if glucose >300 mg/dL.' Keep patients hydrated, especially when glucose levels are high (e.g., >300 mg/dL)." 1
Hypoglycemia (glucose 70 mg/dL) in this patient signals that the current reactive approach is causing dangerous swings; a scheduled regimen will provide more stable glucose control. 45
Approximately 48% of nursing home residents on insulin have hyperglycemia ≥250 mg/dL alone, 7% have hypoglycemia <70 mg/dL alone, and 12% have both, underscoring the need for a balanced basal-bolus approach. 4

Hypoglycemia Management

Treat any glucose <70 mg/dL immediately with 15 g of fast-acting carbohydrate (e.g., 4 glucose tablets or 4 oz juice), recheck in 15 minutes, and repeat if needed. 3
If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10–20% before the next administration. 37
Never use rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk. 3

Expected Clinical Outcomes

With a properly implemented basal-bolus regimen, ~68% of patients achieve mean glucose <140 mg/dL, compared with ~38% on sliding-scale alone. 12
Basal-bolus therapy does NOT increase hypoglycemia incidence when titrated according to protocol, unlike inadequate sliding-scale regimens. 12
Glucose fluctuations will stabilize within 3–7 days after transitioning to scheduled insulin. 3

Common Pitfalls to Avoid

Do NOT continue sliding-scale insulin as the sole regimen when glucose repeatedly exceeds 180 mg/dL or drops to 70 mg/dL; it is inferior and unsafe. 12
Do NOT give Lantus or Humalog "if glucose >200 mg/dL"—both must be scheduled regardless of glucose level. 188
Do NOT delay adding prandial insulin when basal insulin alone fails to control daytime glucose. 3
Do NOT rely solely on correction doses without adjusting scheduled basal and prandial insulin; this perpetuates inadequate control. 13

Summary Algorithm

Calculate average total daily insulin from past 5–7 days (or start with 0.3–0.5 U/kg/day for severe hyperglycemia). 13
Give 50% as scheduled basal insulin (Lantus) once daily at the same time every day. 1388
Give 50% as scheduled prandial insulin (Humalog) divided among three meals, administered 0–15 minutes before eating. 13
Add correction doses (2 U for glucose >250 mg/dL, 4 U for >350 mg/dL) in addition to scheduled prandial doses. 3
Titrate basal insulin by 2–4 U every 3 days based on fasting glucose. 7
Titrate prandial insulin by 1–2 U every 3 days based on post-prandial glucose. 3
Monitor daily fasting, pre-meal, post-prandial, and bedtime glucose to guide adjustments. 37
Treat hypoglycemia <70 mg/dL immediately and reduce the implicated insulin dose by 10–20%. 37

Have a follow-up question?